Scientific Program

Program Schedule

 

Click Here to Download the Program Book PDF


Book of Abstracts


Book of Abstracts


SaturdayJuly 13, 2019

  • 08:45 - 15:30

    IUSTI Canada - ASTDA Career Development Symposium for Emerging Investigators and Program Leaders (*Limited spaces available)

    Location: MR 11+12, East Building, Vancouver Convention Centre

    *For more information Send Email


    Moderator: Marc Steben

    09:00 - 09:20 Introductions - Marc Steben

    09:00 - 10:30 “Speed Intros”

    10:30 - 10:45 Coffee Break

    10:45 - 11:45 Finding Funding:
    Canada: Scott Gray-Owen
    USA: Julie Dombrowski
    Industry:
    Ajith Joseph, Abbott
    Courtney Maus, BD
    Anu Rebbapragada, Hologic
    Chris McGowin, Roche

    11:45 - 13:00 Lunch / Career Panel
    Chris L. McGowin, Max Chernesky (TBC), Petra Smyczek

    13:00 - 14:00 Manuscript Workshop - Bill Miller

    14:00 - 15:00 Small Group Discussions
    • Work-life balance and avoiding burnout: Abigail Norris-Turner
    • How to grow your network/increase visibility: Max Chernesky (TBC)
    • Thorny issues in collaboration: Julie Dombrowski
    • Balancing clinical, research and teaching: Irene Martin (TBC)
    • Community engagement, health departments & advisory boards: Marc Steben

    15:00 - 15:30 Conclusion and Next Steps

  • 19:30 - 22:00

    Presidents' Dinner (Invitation Only)

    Location: The Teahouse Stanley Park

SundayJuly 14, 2019

  • 09:00 - 17:00

    Pre-Congress Symposium 1 - Phase specific strategies for STI and HIV control redux: Resurgence, concentrations, networks, key populations, and magic bullets

    Location: MR 11+12, East Building, Vancouver Convention Centre

    Organized by Sevgi Aral and James Blanchard

    Chair: James Blanchard, University of Manitoba, Canada

    09:00 - 09:05 Welcome and Introductions

    09:05 - 09:35 STI/HIV prevention today
    - Sevgi Aral, Centers for Disease Control and Prevention, USA

    09:35 - 10:05 Background and progress in phase-specific strategies
    - Judy Wasserheit, University of Washington, USA 

    10:05 - 10:35 Emerging research methods and collaborations to improve program design and implementation
    - Geoff Garnett, Bill & Melinda Gates Foundation, USA

    11:00 - 11:30 Appraising epidemic phases and transmission dynamics – insights from epidemiology and mathematical modeling
    - Sharmistha Mishra, St. Michael's Hospital, Canada

    11:30 - 12:00 Art-based prevention: Observations on the pathway from efficacy to effectiveness
    - Myron Cohen, University of North Carolina, USA

    12:00 - 12:30 Round Table Discussion – What have we learned from modeling about targeting for HIV prevention, and what more do we need to learn?
    Moderator: Sevgi Aral, Centers for Disease Control and Prevention, USA
    • Geoff Garnett
    • Sharmistha Mishra
    • Judy Wasserheit
    • Myron Cohen

    Chair: Stephen Moses, University of Manitoba, Canada

    13:30 - 14:00 How can we improve resource allocation and management in the changing global HIV landscape?
    - David Wilson, World Bank, USA

    14:00 - 14:30 HIV and STI prevention program design: Back to the basics
    - James Blanchard, University of Manitoba, Canada

    14:45 - 15:15 Challenges in the implementation of new interventions for HIV/STI
    - Helen Ward, Imperial College London, UK

    15:15 - 15:45 Phase shifts in HIV and STI epidemics in Sub-Saharan Africa: Implications for programs and science
    - Richard Hayes, London School of Hygiene & Tropical Medicine, UK

    15:45 - 16:15 Round Table Discussion – Phase Specific Strategies and future priorities for Program Science
    Moderator: Marissa Becker, University of Manitoba, Canada
    • David Wilson
    • Helen Ward
    • James Blanchard
    • Richard Hayes

    16:15 - 16:30 Wrap-up – Concluding Remarks
    - Sevgi Aral, Centers for Disease Control and Prevention, USA
  • 08:00 - 12:00

    Pre-Congress Symposium 2 - The global challenges and opportunities of STIs in pregnancy

    Location: MR 9, East Building, Vancouver Convention Centre

    Organized by University of California Los Angeles

    08:00 - 08:10 Welcome
    - Jackie McDowell, Cepheid

    08:10 - 08:30 Overview
    - Jeffrey D Klausner, University of California, Los Angeles, USA

    08:30 - 08:55 Curable STIs in pregnant women living in Brazil; A challenge ripe for intervention
    - Nava Yeganeh, University of California, Los Angeles, USA

    08:55 – 09:20 Syndromic management for STIs during pregnancy just doesn't cut it anymore: Implementing diagnostic screening to reduce adverse birth outcomes in South Africa
    - Andrew Medina-Marino, Foundation of Professional Development, South Africa

    09:20 - 09:45 Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-income settings: the WANTAIM Trial, Papua New Guinea
    - Andrew Vallely, Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea & The Kirby Institute, UNSW Sydney, Australia

    09:45 - 10:10 Antenatal Chlamydia trachomatis and Neisseria gonorrhoeae testing compared to syndromic management in Botswana: A cost-effectiveness study
    - Adriane Wynn, University of California, San Diego, USA

    10:10 - 10:20 Break

    10:20 - 10:45 Chlamydia trachomatis screening and treatment among pregnant women in China: Evidence and challenges
    - Weiming Tang, University of North Carolina at Chapel Hill, USA

    10:45 - 11:10 The ASPIRE Trial – aiming for safe pregnancies: Reducing malaria and infections of the reproductive tract in Zambia
    - Matthew Chico, London School of Hygiene & Tropical Medicine, United Kingdom

    11:10 - 11:35 Enhancing nutrition and antenatal infection treatment for maternal and child health (ENAT) study: Screening and treating genitourinary tract infections to improve birth outcomes in Amhara, Ethiopia
    - Rose L. Molina, Beth Israel Deaconess Medical Center, Harvard Medical School, USA

    11:35 - 12:00 Summary and next steps
    - Nicola Low, Institute of Social and Preventive Medicine, University of Bern, Switzerland

  • 08:00 - 12:00

    Pre-Congress Symposium 3 - Understanding variability and improving the reproducibility of genital microbiome research

    Location: MR 2+3, East Building, Vancouver Convention Centre

    Organized by Jen Balkus

    Speaker(s):

    08:00 - 08:15 Introductions and motivations for the Vaginal Microbiome Laboratory Variability Project (MLVP)
    - Jen Balkus, University of Washington, USA

    08:15 - 08:30 Overview of the Vaginal Microbiome Laboratory Variability Project
    - David Fredricks, Fred Hutchinson Cancer Research Center, USA

    08:30 - 09:00 Laboratory challenges and opportunities to reduce variability: Lessons learned from the MLVP
    - Sujatha Srinivasan, Fred Hutchinson Cancer Research Center, USA & Darrell Dinwiddie, University of New Mexico, USA

    09:00 - 09:30 Bioinformatics challenges and opportunities to reduce variability: Lessons learned from the MLVP
    - Johanna Holm, University of Maryland & Liam Van Der Pol, University of Alabama, USA

    09:30 - 10:00 Coffee break

    10:00 - 10:20 Statistical analyses and challenges for assessing variability
    - Jim Hughes, University of Washington, USA & Pawel Gajer, University of Maryland, USA

    10:20 - 10:40 Successes and challenges of implementing the MLVP and opportunities to improve reproducibility moving forward
    - Jacques Ravel, University of Maryland, USA

    10:40 - 11:20 Round table discussion with other experts engaged in vaginal microbiome research

    Panel discussion with

    - Carolyn Deal (NIAID/DMID)

    - Jennifer Fettweis (VCU)

    - Doug Kwon (Ragon Institute)

    - Deborah Money (UBC)

    11:20 - 11:30 Wrap-up
    - Jen Balkus, University of Washington, USA

  • 08:00 - 12:00

    Pre-Congress Symposium 4 - Shaking the trees: Optimizing treatment and antimicrobial stewardship for STIs

    Location: MR 1, East Building, Vancouver Convention Centre

    Organized by Arlene C. Seña

    Facilitators:

    Laura Bachmann, MD, MPH - Medical Director, CDC Division of STD Prevention
    Christine Johnson, MD, MPH - Associate Professor, University of Washington at Seattle; Medical Director, University of Washington STD Prevention Training Centers

    Speaker(s):

    Talk 1. Global STI trends and priorities for antimicrobial resistance
    - Teodora Elvira Wi, MD
    Medical Officer, STI Department of Reproductive Health and Research, World Health Organization

    Talk 2. Pharmacokinetics and pharmacodynamics – factors to consider for STI treatment
    - Jane Hocking, MD
    Professor, Centre for Epidemiology and Biostatistics, Melbourne, Melbourne School of Population and Global Health, University of Melbourne

    Talk 3. Resistance emergence: Single vs combination therapies
    - George L. Drusano, MD
    Professor and Director, Institute for Therapeutic Innovation, University of Florida

    Talk 4. Molecular tests for prediction of antimicrobial resistance (or susceptibility) in N. gonorrhoeae and M. genitalium
    - Magnus Unemo, PhD
    Associate Professor, Director, WHO Collaborating Centre for gonorrhoea and other STIs, Swedish Reference Laboratory for STIs, Örebro University Hospital, Sweden

    Talk 5. Are we ready for this? - Antimicrobial stewardship for STIs
    - Arlene C. Seña, MD, MPH
    Associate Professor, Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill; Medical Director, Durham County Department of Public Health

     

  • 08:00 - 12:00

    Pre-Congress Symposium 5 - The resurgence of syphilis: What have we learned and how can we respond?

    Location: MR 8+15, East Building, Vancouver Convention Centre

    Organized by David Lewis and Gwenda Hughes

    Refreshments supported by Western Sydney Sexual Health, University of Sydney, Australia

    Speaker(s):

    Talk 1. Syphilis: A historical overview
    - David Lewis, University of Sydney, Australia

    Talk 2. Keynote Lecture: Syphilis pathogenesis: What we know and what we need to know
    - Sheila Lukehart, University of Washington, USA

    Talk 3. The application of modern technologies to the goal of syphilis elimination
    - Caroline Cameron, University of Victoria, Canada

    Talk 4. What can we learn about syphilis from whole genome sequencing of global Treponema pallidum strains
    - Nick Thomson, Sanger Institute, UK

    Talk 5. Syphilis in the context of HIV co-infection
    - Khalil Ghanem, Johns Hopkins University, USA

    Talk 6. Syphilis, the great imitator: Unusual case presentations of syphilis in adults
    - Somesh Gupta, All India Institute of Medical Sciences, India

    Talk 7. Recent trends in syphilis in women and congenital syphilis in developed countries: A changing epidemiology?
    - Gwenda Hughes, Public Health England, UK

    Talk 8. Drivers and determinants for the rising incidence of syphilis in men-who-have-sex-with-men
    - Kyle Bernstein, Centers for Disease Control and Prevention, USA

    Talk 9. Responding to syphilis in China: The importance of key populations
    - Xiang-Sheng Chen, National Center for STD Control, China

  • 08:00 - 12:00

    Pre-Congress Symposium 6 - The role of brief behavioural interventions in a combination prevention approach to sexually transmitted infections, including HIV

    Location: MR 19, East Building, Vancouver Convention Centre

    Organized by Igor Toskin

    PART I - SRH behavioural interventions Global State of Affairs

    Co-chairs: Igor Toskin, World Health Organization, Switzerland - King Holmes, Dept. of Global Health & Medicine, University of Washington, USA - Carmen Logie, University of Toronto, Canada

    Talk 1. WHO perspective on behavioural interventions
    - Igor Toskin, World Health Organization, Switzerland

    Talk 2. Exploring the landscape of behavioural HIV/STI prevention interventions in Canada
    - Carmen Logie, University of Toronto, Canada

    Talk 3. Scientific evidence of effectiveness of behavioural interventions for shifting sexual health outcomes
    - Rob Stephenson, Center for Sexuality and Health Disparities, University of Michigan, USA

    Talk 4. Delivering behavioural interventions through e-health and mHealth technologies
    - Keith Horvath, University of Minnesota, USA

    Talk 5. Screening of a behavioural intervention using Motivational Interviewing (MI)

    PART II - Country perspectives behavioural interventions and WHO Brief Sexuality-related Communication (BSC) feasibility study

    Co-chairs: Igor Toskin, World Health Organization, Switzerland - Carmen Logie, University of Toronto, Canada

    Talk 6. MI in France
    - Experiences and results of MI-training for pharmacists
    - MI-training for counsellors of an HIV phone-service, 'SIDA-infoservice'
    - Thierry Troussier, Chaire UNESCO Santé sexuelle et Droits humains, Paris, France

    Talk 7. Introduction of the WHO BSC feasibility study
    - Sofia de Vasconcelos, World Health Organization, Switzerland

    Talk 8. WHO BSC feasibility study in Peru: Results of the formative phase and next steps
    - Carlos Caceres, Universidad Peruana Cayetano Heredi, Peru

    Talk 9. WHO BSC feasibility study in Moldova: Populations and objectives
    - Natalia Bakunina, World Health Organization, Switzerland /Larisa Boderscova, WHO, Moldova

    Talk 10. Behavioural intervention showcase (video)
    - youth counselling
    - M-health intervention
    - BSC training video Peru

  • 08:00 - 12:00

    Pre-Congress Symposium 7 - Ibero-American Network on Gay Men, others MSM and Trans Studies (RIGHT) and the Latin American Men Who Have Sex With Men Internet Survey (LAMIS)

    Location: MR 13, East Building, Vancouver Convention Centre

    Organized by Valeria Stuardo Ávila

    Speaker(s):

    Talk 1. The Ibero-American network on gay men, others MSM and trans studies (RIGHT)
    - Valeria Stuardo Ávila, Escuela de Salud Pública, Facultad de Medicina, Universidad de Chile, Santiago, Chile

    Talk 2. The methodological framework of Latin American men who have sex with men internet survey (LAMIS) in light of the prior EMIS studies
    - Ulrich Marcus, Robert Koch Institute, Berlin, Germany

    Talk 3. Implementation of LAMIS as a collaborative effort in Latin American countries
    - Carlos Cáceres, Centro de Investigación Interdisciplinaria en Sexualidad, SIDA y Sociedad, Universidad Peruana Cayetano Heredia, Lima, Peru

    Talk 4. General results - descriptive analysis of LAMIS 2018: Implications for collaborative public policies in the Latin American region
    - Jordi Casabona, Centre d'EstudisEpidemiològics sobrelesInfeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Barcelona, Spain

    Talk 5. HIV among MSM and TGW in Brazil: Different approaches, same striking results
    - Maria Amélia Veras, Faculdade de Ciências Médicas daSanta Casa de São Paulo, Núcleo de Pesquisa em Direitos Humanos e Saúde LGBT, Brazil

     

  • 08:00 - 12:00

    Pre-Congress Symposium 8 - The next frontier of treatment and prevention of sexually transmitted infections: Expedited partner therapy use in heterosexuals, adolescents, men who have sex with men, and transgender women

    Location: MR 14, East Building, Vancouver Convention Centre

    Organized by Okeoma Mmeje

    Speaker(s):

    Talk 1. Overview of expedited partner therapy
    - Okeoma Mmeje, University of Michigan, USA

    Talk 2. Expedited partner therapy use in heterosexuals
    - Jenell Coleman, Johns Hopkins University, USA

    Talk 3. Expedited partner therapy use in adolescents & school-based clinics
    - Nicole Speck, University of Michigan, USA

    Talk 4. Support for expedited partner therapy use in men who have sex with men & transgender women
    - Kristi Gamarel, University of Michigan, USA
    - Raha Richardson, University of Michigan, USA

    Talk 5. Implications for expedited partner therapy use in men who have sex with men
    - Julia Schillinger, Centers for Disease Control and Prevention, USA

     

  • 13:00 - 15:00

    Pre-Congress Symposium 9 - Highlights of selected topics from the Canadian STI guidelines

    Location: MR 8+15, East Building, Vancouver Convention Centre

    Organized by Ameeta Singh

    Chair(s):

    Max Chernesky, McMaster University, Canada
    Margaret Gale-Rowe, PHAC, Canada

    Speaker(s):

    Talk 1. Mycoplasma genitalium
    - Annie-Claude Labbe, Université de Montréal, Canada

    Talk 2. Gonorrhea: Approach to management in the setting of rising antimicrobial resistance
    - Ameeta Singh, University of Alberta, Canada

    Talk 3. Prenatal screening for STBBIs
    - Mark Yudin, University of Toronto, Canada

  • 15:00 - 17:00

    Pre-Congress Symposium 10 - IUSTI Canada symposium: Innovative platforms and interventions against gonorrhoea

    Location: MR 8+15, East Building, Vancouver Convention Centre

    Organized by Jo-Anne Dillon, President, IUSTI Canada

    Speaker(s):

    Talk 1. International dissemination of ceftriaxone-resistant Neisseria gonorrhoeae strain (FC428)
    - Petra Smyczek, Alberta Health Services, Edmonton, Alberta, Canada

    Talk 2. What’s new in gonococcal antimicrobial resistance and diagnosis of AMR
    - Jo-Anne Dillon, Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon, Canada

    Talk 3. New anti-gonococcal antibiotics, discovery and pipeline
    - Gerry Wright, McMaster University, Hamilton, Ontario, Canada

    Talk 4. Almost Human: Advanced preclinical models for gonococcal vaccine and drug development
    - Scott Gray-Owen, University of Toronto, Toronto, Ontario, Canada

  • 13:00 - 17:00

    Pre-Congress Symposium 11 - Proteomics

    Location: MR 14, East Building, Vancouver Convention Centre

    Organized by Leonard Foster

    Speakers:

    Talk 1. Metaproteomics for discovering mechanisms and biomarkers in the vaginal microbiome
    - Adam Burgener, University of Manitoba, Canada

    Talk 2. Towards the development of a SISCAPA assay for direct measurement of T. pallidum proteins in bodily fluids
    - Morty Razavi, SISCAPA Assay Technologies (SAT), Canada

    Talk 3. When and how to bring in proteomics
    - Leonard Foster, UBC, Canada

    Talk 4. Practical considerations for moving proteomic tests into the clinic
    - Angela Fung, Clinical Chemist, St. Paul’s Hospital, Vancouver, Canada

  • 13:00 - 17:00

    Pre-Congress Symposium 12 - Sexually transmitted infection vaccines - opportunities for research, development and implementation

    Location: MR 1, East Building, Vancouver Convention Centre

    Organized by the Sexually Transmitted Infections Vaccine Consortium, based in British Columbia (STRIVE-BC)

    Speaker(s):

    Opening remarks
    - Troy Grennan, University of British Columbia & the BC Centre for Disease Control, Canada

    Talk 1. The current landscape of STI vaccines
    - Carolyn Deal, National Institute of Allergy and Infectious Diseases, USA

    Talk 2. STI vaccine roadmap
    - Sami Gottlieb, World Health Organization, Switzerland

    Talk 3. Will the world accept STI vaccines? Lessons from the HPV vaccine
    - Simon Dobson, University of British Columbia, Canada

    Talk 4. STI vaccine Development updates: Current science and future directions
    - Syphilis: Caroline Cameron, University of Victoria, Canada
    - Gonorrhea: Rino Rappuoli, GSK Vaccines, Italy
    - Chlamydia: Kevin Hybiske, University of Washington, USA
    - HSV: Anna Wald, University of Washington, USA

    Talk 5. Priority setting for future science & research (panel discussion) 
    - Moderated by: Scott Lamontagne, University of Washington, USA
    - Caroline Cameron, University of Victoria, Canada
    - Carolyn Deal, National Institute of Allergy and Infectious Diseases, USA
    - Charu Kaushic, Canadian Institutes of Health Research, Canada
    - Rino Rappuoli, GSK Vaccines, Italy
    - Peter Dull, Bill & Melinda Gates Foundation

    Talk 6. Implementation challenges in public health (panel discussion) 
    - Moderated by: Scott Lamontagne, University of Washington, USA
    - Sami Gottlieb, World Health Organization, Switzerland
    - Bonnie Henry, Government of British Columbia, Canada
    - Manish Sadarangani, Vaccine Evaluation Center, Canada
    - Peter Dull, Bill & Melinda Gates Foundation

    Closing remarks
    - Manish Sadarangani, Vaccine Evaluation Centre, Canada and Gina Ogilvie, School of Population and Public Health (SPPH), Canada

  • 13:00 - 17:00

    Pre-Congress Symposium 13 - Accelerating development and implementation of point-of-care tests for sexually transmitted infections: Challenges, achievements, and way forward

    Location: MR 9, East Building, Vancouver Convention Centre

    Organized by Igor Toskin

    PART I - STI POCT Global State of Affairs

    Co-chairs: Igor Toskin, World Health Organization, Switzerland and Rosanna Peeling, London School of Hygiene and Tropical Medicine, United Kingdom

    Talk 1. WHO Initiative on STI POCT: vision, progress and way forward
    - Igor Toskin, World Health Organization, Switzerland

    Talk 2. Epidemiology of gonococcal infections in infertile populations: Systematic review and meta-analytics
    - Hiam S. Chemaitelly, Weill Cornell Medical College, Qatar

    Talk 3. POC diagnostic tests and technologies for sexually transmitted infections: A landscape analysis
    - Maurine Murtagh, World Health Organization, Switzerland

    Talk 4. Policy development and Implementation successes and challenges in introducing STI POCTs
    - Rosanna Peeling, London School of Hygiene and Tropical Medicine, United Kingdom

    Talk 5. Rapid AMR-test technology to enable immediate accurate treatment and enhance AMR surveillance
    - Tariq Sadiq, St George's University of London, United Kingdom

    Talk 6. Sample self-collection and STI self-testing
    - Ellen Kersh, Centers for Disease Control and Prevention (CDC), Atlanta, USA

    PART II - Country Perspective and Current WHO STI POCT Evaluation Studies

    Co-chairs:
    Ranmini Kularatne, Centre for HIV & STIs, National Institute for Communicable Diseases, Johannesburg, South Africa and Ron Ballard, World Health Organization, Switzerland

    Talk 7. Independent multi-country clinic-based evaluation of STI POCTs: study design, methodology, research instruments, data management system and current status
    - Soe Soe Thwin, World Health Organization, Switzerland
    - Massimo Mirandola, University of Verona, UoV, Italy
    - Karel Blondeel, World Health Organization, Switzerland

    Talk 8. Independent multi-country clinic-based evaluation of STI POCTs: internal quality control and external quality assurance:
    - NG/CT/TV - Ellen Kersh, Centers for Disease Control and Prevention (CDC), Atlanta, USA
    - HIV/syphilis - Kelly Andrewartha, Flinders University, Adelaide, Australia

    Talk 9. Independent multi-country clinic-based evaluation of STI POCTs, implementation in selected sites:
    - Italy: challenges and opportunities in piloting the study procedures and engaging with MSM in an outpatient setting - Maddalena Cordioli, University of Verona, UoV, Italy

    - South Africa: current status, programmatic needs and challenges - Ranmini Kularatne, Centre for HIV & STIs, National Institute for Communicable Diseases, Johannesburg, South Africa

    - Peru - Carlos Cáceres, Universidad Peruana Cayetano Heredia, Peru

    Talk 10. Independent multi-country clinic-utility evaluation of STI diagnostics: study design, methodology, research instruments, data management system and current status
    - Jordi Casabona, Centre d’Estudis Epidemiològics sobre les ITS i Sida de Catalunya, CEEISCAT, Spain

  • 13:00 - 17:00

    Pre-Congress Symposium 14 - Preparing sexual health services for antimicrobial resistance bacteria: A global perspective

    Location: MR 2 +3, East Building, Vancouver Convention Centre

    Workshop organising committee:

    Dr Katy Turner, Prof Nicola Low, Dr Yonatan Grad, Prof Teodora Wi, Prof Magnus Unemo, Dr Minttu Ronn

    The workshop will provide a cross-disciplinary approach to the challenge of antimicrobial resistant (AMR) bacteria causing sexually transmitted infections (STIs). Antimicrobial resistance is a complex challenge, most of the data and published work is focused on high income settings, but the main burden of disease due to drug resistance will occur in low and middle income (LMIC) countries. Please tweet from the workshop using the following hashtags.

    #AMRSTI #ISSTDR2019 #IUSTIWorld2019

    Speaker(s):

    13:00 Session 1 - setting the scene

    WHO perspectives on the threat of AMR – global challenges of surveillance
    - Prof Teodora Wi

    Antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium
    - Prof Magnus Unemo

    Epidemiological trends in Neisseria gonorrhoeae and implications for services
    - Prof Nicola Low

    13:15 Panel discussion

    13:45 Quantifying the surveillance needed to sustain genetic marker-based antibiotic resistance diagnostics
    - Prof Yonatan Grad

    13:50 Modelling evolution of resistance over time in N. gonorrhoeae
    - Dr Lilith Whittles

    14:00 Modelling the impact of resistance on gonorrhoea epidemiology
    - Dr Katy Turner

    14:30 Session 2 - Global perspective

    14:30 Modelling vaccination as a way to control AMR
    - Dr Laith Abu Raddad

    14:45 Impact of vaccination on the sustainable transmission of Neisseria gonorrhoeae drug-resistant strains
    - Dr Shaheen Seedat

    14:55 The Brazilian public health policy for gonorrhea
    - Dr Pâmela Cristina Gaspar

    15:10 Gonorrhea in the era of AMR, diagnostic needs for improved antimicrobial stewardship in low and middle income countries
    - Dr Cecilia Ferreyra

    15:25 Panel discussion

  • 13:00 - 17:00

    Pre-Congress Symposium 15 - Understanding the costs and benefits of sexual health services and interventions: A guide for clinicians and researchers

    Location: MR 13, East Building, Vancouver Convention Centre

    Organized by Dr Louise Jackson

    Coffee & networking

    13:00 - 13:15 The economics of sexual health services and interventions – a service perspective
    Professor Jonathan Ross

    13:15 - 14:00 Overview of key principles in analysing costs and benefits in Sexual Health
    Professor Tracy Roberts

    14:00 - 14:45 A practical guide to collecting and analysing data on costs and benefits
    Dr Louise Jackson

    14:45 – 15:00 Break (coffee & networking)

    15:00 - 16:00 Activity – analysing an economic study

    16:00 - 16:40 Workshop – developing an evaluation

    16:40 - 17:00 Synthesis & next steps
    Professor Jonathan Ross & Professor Tracy Roberts

  • 13:00 - 17:00

    Pre-Congress Symposium 16 - BS21 Network: Behavioural surveillance for HIV and STIs in the 21st century

    Location: MR 19, East Building, Vancouver Convention Centre

    Organized by Lisa McDaid

    Chair(s): 

    Lisa McDaid, University of Glasgow, UK

    Speaker(s): 

    Talk 1. Introduction to contemporary behavioural surveillance
    - Lisa McDaid, University of Glasgow, UK
    - Nathan Lachowsky, University of Victoria, Canada

    Talk 2. The current state of behavioural surveillance (panel discussion) 
    - Nathan Lachowsky, University of Victoria, Canada
    - Patrick Sullivan, Emory University, USA
    - Benjamin Bavinton, Kirby Institute, Australia
    - Peter Saxton, University of Auckland, New Zealand
    - Jamie Frankis, Glasgow Caledonian University, UK

    Talk 3. Changing HIV epidemics and representativeness of behavioural surveillance research (panel discussion) 
    - Peter Saxton, University of Auckland, New Zealand
    - Nathan Lachowsky, University of Victoria, Canada
    - Jamie Frankis, Glasgow Caledonian University, UK

    Talk 4. Why do we still need behavioural surveillance in the age of biomedical HIV prevention? (panel discussion) 
    - Benjamin Bavinton, Kirby Institute, Australia
    - Jamie Frankis, Glasgow Caledonian University, UK
    - Patrick Sullivan, Emory University, USA

    Talk 5. Neglected populations and regions (panel discussion) 
    - Jacqueline Gahagan, Dalhousie University, Canada
    - Tyrone Curtis, University College London, UK
    - Harlan Pruden, BC Centre for Disease Control, Canada

    Talk 6. Biobehavioural surveillance: The challenges of biological sampling (panel discussion) 
    - Patrick Sullivan, Emory University, USA
    - Jamie Frankis, Glasgow Caledonian University, UK
    - John Kim, Public Health Agency of Canada, Canada

    Talk 7. Community engagement in behavioural surveillance research (panel discussion) 
    - David Brennan, University of Toronto, Canada
    - Jeff Morgan, CBRC - Community Based Research Centre for Gay Men’s Health, Canada
    - Lisa McDaid, University of Glasgow, UK

    Talk 8. Application of theoretical models to periodic behavioural surveillance and what is missed if you do not have one (panel discussion) 
    - Paul Flowers, Glasgow Caledonian University, UK
    - Kiffer Card, Simon Fraser University, Canada

  • 17:30 - 18:30

    Welcome Ceremony

    Location: Ballroom, East Building, Vancouver Convention Centre
  • 18:30 - 19:30

    Opening Keynote Lecture - 2019 ISSTDR Prestigious Lecture: Bacterial STI vaccines - eternal dream or future reality?

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    Rino Rappuoli, GSK Vaccines, Italy

  • 19:30 - 21:00

    Welcome Reception

    Location: Exhibit Hall A East Building Vancouver Convention Centre

MondayJuly 15, 2019

  • 07:00 - 08:00

    Clinical Case Series - Syphilis: The great imitator

    Location: MR 8+15, East Building, Vancouver Convention Centre

    Talk 1. Neurosyphilis is more common among malignant syphilis: Based on case series evidence 
    - Pingyu Zhou, Shanghai Skin Disease Hospital, China

    Talk 2. A case series of syphilis masquerading as thoracic malignancy
    - Jessica Doctor, Guys' and St Thomas's NHS Foundation Trust, UK

    Talk 3. Syphilis as fibromyalgia with unexplained hepatosplenomegaly
    - Jackie Sherrard, Buckinghamshire Healthcare NHS Trust, UK

  • 07:00 - 08:00

    ASTDA Young Investigator Mentor/Mentee Breakfast Session: Meet the editor!

    Location: MR 11+12, East Building, Vancouver Convention Centre

    Speaker:

    Bill Miller, Editor in Chief, Sexually Transmitted Diseases

  • 08:15 - 08:50

    Plenary 1 - The role of genomics in the diagnosis and management of STIs

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    Helena Seth-Smith, University Hospital Basel, Switzerland

  • 08:50 - 09:25

    Plenary 2 - Identification and management of complicated syphilis

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    Christina Marra, University of Washington, USA

  • 09:25 - 10:00

    Plenary 3 - Engaging indigenous communities in health programs

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    Charlotte Loppie, University of Victoria, Canada

  • 10:00 - 10:15

    Welcome by Elder, Coast Salish Nations

    Location: Ballroom, East Building, Vancouver Convention Centre
  • 10:15 - 10:45

    Coffee Break

    Location: Exhibit Hall, East Building, Vancouver Convention Centre
  • 10:45 - 12:15

    Symposium 1 - Program science/implementation science methods: Moving beyond the traditional RCT

    Location: MR 11+12, East Building, Vancouver Convention Centre

    Talk 1. Must the evaluation of complex interventions be complex? Learning from the impact evaluation of DREAMS 
    - Isolde Birdthistle, The London School of Hygiene & Tropical Medicine, UK 

    Talk 2. HPTN 071 (PopART): Findings and lessons from a non-traditional RCT
    - Richard Hayes, The London School of Hygiene & Tropical Medicine, UK

    Talk 3. Using multiple data sources for programme evaluation: Integration of program monitoring data with other research studies
    - Banadakoppa Ramesh, University of Manitoba, Canada

    Talk 4. Evaluating complex public health issue violence - understanding and measuring violence and evaluating violence interventions - lessons from STRIVE
    - Sinead Delany-Moretlwe, Wits Reproductive Health and HIV Institute, South Africa

  • 10:45 - 12:15

    Symposium 2 - HIV and syphilis self-testing and self-collection: Empowerment, agency and implementation

    Location: MR 1, East Building, Vancouver Convention Centre

    Talk 1. HIV self-testing in Eastern and Southern Africa: The STAR project
    - Maryam Shahmanesh, London’s Global University, UK

    Talk 2. Syphilis self-testing: A nationwide pragmatic study among men who have sex with men in China
    - Cheng Wang, Southern Medical University, China

    Talk 3. HPV self-collection in Peru: Project HOPE
    - Patricia Garcia, Universidad Peruana Cayetano Heredi, Peru

    Talk 4. Empowerment and approaches for stigma reduction: Implementation of HIV self-testing among female sex workers
    - Catherine Oldenburg, University of California, USA

  • 10:45 - 12:15

    Symposium 3 - Epidemiological aspects of STI transmission in MSM

    Location: Ballroom, East Building, Vancouver Convention Centre

    Talk 1. Impact of HIV PrEP on risk compensation and STI epidemiology – what does the evidence show?
    - Helen Ward, Imperial College London, UK

    Talk 2. The role of oral-anal transmission in persistence of chlamydial infection
    - Henry de Vries, University of Amsterdam, Netherlands

    Talk 3. Sexual transmission of N. meningitidis in MSM and implications for public health
    - Anna McNulty, Sydney Sexual Health Centre, Australia

    Talk 4. Hepatitis C in HIV-negative MSM – a growing concern?
    - Axel J. Schmidt, London School of Hygiene and Tropical Medicine, UK

  • 10:45 - 12:15

    Symposium 4 - The impact of advances in diagnostic technology on policy, program and practice (ISSTDR Special Symposium)

    Location: MR 2+3, East Building, Vancouver Convention Centre

    Talk 1. Resistance-guided therapy for M.genitalium: Impact of diagnostic resistance assays on practice and policy
    - Catriona Bradshaw, Central Clinical School, Monash University, Australia

    Talk 2. Point of care and home testing opportunities: Implications for quality public health practice
    - Patricia Dittus, Centers for Disease Control and Prevention, USA

    Talk 3. Home based testing: Unintended consequences and implications for antimicrobial stewardship – Should we be concerned?
    - Paddy Horner, Population Health Sciences, University of Bristol, UK

    Talk 4. Implementing molecular testing to predict Neisseria gonorrhoeae susceptibility in clinical practice
    - Jeffrey D. Klausner, Fielding School of Public Health, US

  • 10:45 - 12:15

    Oral Presentation Session 1 - Development of vaccines for bacterial STIs

    Location: MR 8+15, East Building, Vancouver Convention Centre

    Talk 1. Genetic similarity of gonococcal homologs to meningococcal outer membrane proteins of serogroup B vaccine
    - Henju Marjuki, Centers for Disease Control and Prevention, USA

    Talk 2. Genetic, structural, and surface antigenic variation of Treponema pallidum’s OMPeome: Steps towards a global syphilis vaccine
    - Kelly Hawley, Connecticut Children's Medical Center, USA

    Talk 3. Engineering hybrid bacterial transferrin receptor-based vaccines to confer broad protection against Neisseria gonorrhoeae
    - Scott Gray-Owen, University of Toronto, Canada

    Talk 4. Rabbit immunization with B. burgdorferi expressing T. pallidum TprK and Tp0435 as a novel vaccine design for syphilis
    - Lorenzo Giacani, University of Washington, USA

    Talk 5. A meningococcal native outer membrane vesicle vaccine as a platform for presenting conserved gonococcal antigens
    - Gregory Moe, UCSF Benioff Children's Hospital Oakland, USA

    Talk 6. Meningococcal vesicle vaccines deleted for major outer membrane proteins enhance gonococcal clearance in a murine model
    - Kathryn Matthias, US Food and Drug Administration, USA

  • 10:45 - 12:15

    Oral Presentation Session 2 - Extragenital bacterial STIs: Epidemiology, natural history, testing and antimicrobial resistance

    Location: MR 13, East Building, Vancouver Convention Centre

    Talk 1. What Is the optimal testing strategy for oropharyngeal Neisseria gonorrhoeae in women visiting STI clinics
    - Christian Hoebe, Public Health Service South Limburg, Maastricht University Medical Center (MUMC+), The Netherlands

    Talk 2. Oropharyngeal and genital gonorrhoea among heterosexuals who report sexual contact with partners with gonorrhoea
    - Eric Chow, Alfred Health, Australia

    Talk 3. Antimicrobial resistance in pharyngeal Neisseria gonorrhoeae infection: A cross-sectional study in men who have sex with men
    - Hester Allen, Public Health England, UK

    Talk 4. Incidence and duration of pharyngeal and rectal gonorrhea and chlamydia among high-risk men who have sex with men (MSM)
    - Lindley Barbee, University of Washington, USA

    Talk 5. Inflammatory cytokines in rectal gonorrhea/chlamydia infection and treatment: Towards STI control as HIV prevention for MSM
    - Jesse Clark, UCLA Geffen School of Medicine, USA

    Talk 6. Extragenital Mycoplasma genitalium infections amongst men who have sex with men
    - Rosie Latimer, Monash University, Australia

  • 10:45 - 12:15

    Oral Presentation Session 3 - Persistence and resistance

    Location: MR 9, East Building, Vancouver Convention Centre

    Talk 1. Natural history of genital and oral herpes simplex virus-1 (HSV-1) shedding after first episode genital HSV-1 infection
    - Christine Johnston, University of Washington, USA

    Talk 2. Detection of glycosylated Treponema pallidum proteins: Relevance for diagnostic assays and importance for infection
    - Alloysius Gomez, University of Victoria, Canada

    Talk 3. The European gonococcal antimicrobial surveillance programme findings 2017
    - Michaela Day, Public Health England, UK

    Talk 4. Modelling intervention strategies for preventing spread of extensively drug resistant gonorrhoea strains among Australian MSM
    - Qibin Duan, UNSW Sydney, Australia

    Talk 5. Utility of real-time whole genome sequencing in partner notification and control of Neisseria gonorrhoeae infection
    - Ling Yuan Kong, Leeds Teaching Hospitals NHS Trust, UK

    Talk 6. Vaginal bacteria and risk of incident and persistent infection with high risk sub-types of human papillomavirus
    - Kayla Carter, University of Washington, USA

  • 13:45 - 14:20

    Plenary 4 - 2019 IUSTI Prestigious Lecture - Revising STI treatment guidelines in times of rapidly evolving antimicrobial resistant STIs

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    Jørgen Jensen, Statens Serum Institut, Denmark

  • 14:20 - 14:55

    Plenary 5 - Priorities for research and programmes for trans communities

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    Tonia Poteat, University of North Carolina, USA

  • 14:55 - 15:30

    Plenary 6 - Mathematical modelling, a luxury or a necessity in STD control?

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    Geoff Garnett, Bill & Melinda Gates Foundation, USA

  • 15:30 - 16:15

    Coffee Break

    Location: Exhibit Hall, East Building, Vancouver Convention Centre
  • 16:15 - 17:45

    Symposium 5 - Community engagement, mobilization and empowerment

    Location: MR 2+3, East Building, Vancouver Convention Centre

    Talk 1. Working with community to control HIV/STI: A U.S. local health department perspective
    - Matthew Golden, University of Washington, USA

    Talk 2. Mobilising for health and rights: A history of sex worker activism in India
    - Smarajit Jana, Sonagachi Research and Training Institute, India

    Discussion on how communities can be mobilized and empowered to support HIV/STI control

  • 16:15 - 17:45

    Symposium 6 - Improved models and tools for STI infections

    Location: MR 9, East Building, Vancouver Convention Centre

    Talk 1. Use of cervical explants to study gonococcal pathogenesis
    - Daniel Stein, University of Maryland, USA

    Talk 2. Bringing culture to the uncultured: Long-term culture of the syphilis spirochete, Treponema pallidum
    - Steven Norris, University of Texas, USA

    Talk 3. Pigtailed macaque model of STIs
    - Dorothy Patton, University of Washington, USA

    Talk 4. Chlamydia, trichomonas and syphilis infections in macaques: Effects on simian HIV acquisition
    - Sundaram Ajay Vishwanathan, Center for Disease Control and Prevention, USA

  • 16:15 - 17:45

    Symposium 7 - Sexual health at the intersection of substance use and social inequality

    Location: Ballroom, East Building, Vancouver Convention Centre

    Talk 1. The North American overdose crisis: How structural violence, prohibition, and stigma have paralyzed our response
    - Mark Tyndall, BC Centre for Disease Control, Canada

    Talk 2. Chemsex and new STI/HIV diagnoses among gay, bisexual and other men who have sex with men attending sexual health clinics
    - Aseel Hegazi, St George's University Hospital Foundation Trust, UK

    Talk 3. Challenges in defining Chemsex. Answers for surveillance from EMIS-2017
    - Axel J. Schmidt, London School of Hygiene and Tropical Medicine, UK

    Talk 4. Review of sexualized drug use associated with sexually transmitted infections (STI) in men who have sex with men (MSM)
    - Fiona Guerra, Public Health Ontario, Canada

  • 16:15 - 17:45

    Oral Presentation Session 4 - Antimicrobial resistance in STI pathogens

    Location: MR 1, East Building, Vancouver Convention Centre

    Talk 1. Novel pathway to ceftriaxone resistance in clinical isolates of N. gonorrhoeae via point mutations in the RNA polymerase
    - Yonatan Grad, Harvard T.H. Chan School of Public Health, USA

    Talk 2. Phylogenomic analysis reveals persistence of Neisseria gonorrhoeae clades with reduced susceptibility to cephalosporins
    - Jesse Thomas, US Centers for Disease Control and Prevention, USA

    Talk 3. Prioritizing novel drug targets based on genomics and proteomics approach in Neisseria gonorrhoeae
    - Daman Saluja, University of Delhi, India

    Talk 4. Mycoplasma genitalium parC and gyrA mutations associated with moxifloxacin and sitafloxacin treatment failure
    - Gerald Murray, The Royal Women's Hospital, Australia

    Talk 5. Point-of-care magnetofluidic assay cartridge for Neisseria gonorrhoeae detection and antimicrobial resistance determination
    - Alexander Trick, Johns Hopkins University, USA

    Talk 6. Prediction of available drug targets of Neisseria gonorrhoeae based on codon usage parameter
    - Uma Chaudhry, Bhaskaracharya College of Applied Sciences, University of Delhi, India

  • 16:15 - 17:45

    Oral Presentation Session 5 - Female genital infections, immunology and microbiome

    Location: MR 13, East Building, Vancouver Convention Centre

    Talk 1. Lower genital tract predictors of acute endometritis among women with signs and symptoms of pelvic inflammatory disease (PID)
    - Sharon Hillier, University of Pittsburgh and Magee-Womens Research Institute, USA

    Talk 2.Characterizing the impact of penile-vaginal sex on HIV-susceptible CD4+ T Cell subsets in the female genital tract
    - Avid Mohammadi, University Of Toronto, Canada

    Talk 3. The combined contraceptive vaginal ring increases Th17-related cytokines in the genital tract: A randomized crossover trial
    - Iyaloo Konstantinus, University of Cape Town, South Africa

    Talk 4. The effect of the combined oral contraceptive pill on the vaginal microbiota of women treated for bacterial vaginosis
    - Larissa Ratten, Monash University, Australia

    Talk 5. Cervicovaginal metabolic profiling reveals the interplay between HPV, microbiota and inflammation in cervical carcinogenesis
    - Melissa Herbst-Kralovetz, University of Arizona, USA

  • 16:15 - 17:45

    Oral Presentation Session 6 - STI/HIV treatment efficacy and effectiveness

    Location: MR 11+12, East Building, Vancouver Convention Centre

    Talk 1. Gentamicin for pharyngeal gonorrhea: A single-arm, non-blinded clinical trial
    - Lindley Barbee, University of Washington, USA

    Talk 2. In vitro combination testing and selection of resistance to zoliflodacin combined with six antimicrobials for N. gonorrhoeae
    - Magnus Unemo, World Health Organization Collaborating Centre for Gonorrhoea and Other STIs, Örebro University, Sweden

    Talk 3. Efficacy of resistance guided therapy for Mycoplasma genitalium using doxycycline followed by azithromycin or moxifloxacin
    - Duygu Durukan, Alfred Health, Australia

    Talk 4. Efficacy and cost-effectiveness of HPV vaccine with imiquimod or podophyllotoxin for patients with anogenital warts (HIPvac)
    - Richard Gilson, University College London, UK

    Talk 5. Do treatment rates suffer in a low-touch screening model? New York City sexual health clinics, 2017-2018
    - Kelly Jamison, Centers for Disease Control and Prevention, USA

    Talk 6. Reduction in adherence to antiretroviral therapy during postpartum: Findings from a prospective cohort study
    - Anthony Ajayi, University of Fort Hare, South Africa

  • 16:15 - 17:45

    Oral Presentation Session 7 - Bugs, behaviour and beyond: New challenges for STI control among gay, bisexual and other men who have sex with men

    Location: MR 8+15, East Building, Vancouver Convention Centre

    Talk 1. Multiple lineages of multiresistant shigella in Australia
    - Deborah Williamson, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Australia

    Talk 2. Use of whole-genome sequencing to identify sexual transmission of shigella in men who have sex with men in England
    - Holly Mitchell, University College London, UK

    Talk 3. Sexually transmissible enteric infections in men who have sex with men: Preliminary findings from a cross-sectional study
    - Holly Mitchell, University College London, UK

    Talk 4. Incidence of sexual behaviors and relationship to the urethral microbiota among men who have sex with men (MSM) in Seattle
    - Laura Chambers, University of Washington, USA

    Talk 5. The index case’s partnership status is important in predicting the likelihood of persistence of introduced XDR NG among MSM
    - Ben Hui, UNSW Sydney, Australia

    Talk 6.A RCT to facilitate psychosocial care among high risk MSM in Amsterdam, a SYNdemic BASed INtervention (Syn.bas.In Study)
    - Roel Achterbergh, Public Health Service of Amsterdam, The Netherlands

  • 17:45 - 19:00

    Poster Viewing Session

    Location: Exhibit Hall, East Building, Vancouver Convention Centre
  • 19:30 - 22:00

    Speakers' Dinner (Invitation Only)

    Location: The Vancouver Club

TuesdayJuly 16, 2019

  • 07:00 - 08:00

    Clinical Case Series - Clinical cases from experts

    Location: MR 8+15, East Building, Vancouver Convention Centre

    Talk 1. Dequalinium chloride vaginal tablets for recalcitrant Trichomonas vaginalis (TV): A case report
    - Deborah Goode, Leeds Teaching Hospitals Trust, UK

    Talk 2. Penile intraepithelial neoplasia: Myriad presentations and intractablecourse
    - Somesh Gupta, All India Instiute of Medical Sciences, India

    Talk 3. Persisting urethritis in an immunocompromised patient
    - William Geisler, University of Alabama at Birmingham, USA

  • 07:00 - 08:00

    ASTDA Young Investigator Mentor/Mentee Breakfast Session: Meet the NIH!

    Location: MR 11+12, East Building, Vancouver Convention Centre

    Speaker:

    Carolyn Deal, Chief, STD Branch, National Institute of Allergy and Infectious Disease, NIH

  • 08:15 - 08:50

    Plenary 7 - Global trends in HIV in the era of combination prevention – what progress have we made towards elimination?

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    Wafaa El-Sadr, Columbia University, USA

  • 08:50 - 10:00

    Plenary 8 - #MeToo movement, systems of power and sexual health and wellbeing: The widening of the #MeToo movement

    Location: Ballroom, East Building, Vancouver Convention Centre

    Panel Speakers:

    1. Journalism – Irin Carmon, Senior Correspondent, New York Magazine & CNN Contributor, USA

    2. Academic Researcher - Dr. Rebecca Thurston, University of Pittsburgh, USA: MeToo and women’s health: Harassment, trauma, and midlife women’s cardiovascular health

    The Plenary Panel “#MeToo Movement, Systems of Power and Sexual Health and Wellbeing: The Widening of the #MeToo Movement” will bring together expert speakers to discuss the impact and implications of the #MeToo movement for sexual health, social justice and equity.

    Presentation: The MeToo Movement’s 2019 PSA Campaign
    This panel will show the new campaign from the #Me Too Movement from creative agency Deutsch and #MeToo movement creator Tarana Burke. The videos focus on the dignity, humanity and healing of survivors of sexual violence. They feature firsthand accounts and reflections from four survivors of sexual violence and abuse, including Terry Crews. "In the year that's gone by, I've learned that silence is violence," says the "Brooklyn Nine-Nine" star in the video. "I will not be shamed. I did nothing wrong."

  • 10:00 - 10:15

    Welcome by Elder, Coast Salish Nations

    Location: Ballroom, East Building, Vancouver Convention Centre
  • 10:15 - 10:45

    Coffee Break

    Location: Exhibit Hall, East Building, Vancouver Convention Centre
  • 10:45 - 12:15

    Symposium 8 - “Elders teach and youth reach”: Indigenous conversations on sexual health

    Location: MR 2+3, East Building, Vancouver Convention Centre

    Aboriginal Health Elders Advisory Council at Vancouver Coastal Health
    Yuúusnewas program at YouthCO HIV & Hep C Society

    Speakers:
    The idea for this symposium was developed through discussion with Elders from the Aboriginal Health Elders Advisory Council at Vancouver Coastal Health. This Council includes Elders from the Coast Salish peoples on whose land this conference is held, specifically the Sḵwx̱wú7mesh (Squamish), Sel̓íl̓witulh (Tsleil-Waututh), and xʷməθkʷəy̓əm (Musqueam) Nations, and from Nations from the Four Directions.
    The Aboriginal Health Elders Advisory Council will be leading this symposium in partnership with the Yuúusnewas program at YouthCO HIV & Hep C Society. The Yuúusnewas program is an Indigenous youth-led program that centres Indigenous teachings in conversations about sexual health and harm reduction. Through workshops and cultural activities, this team of educators creates spaces for all Indigenous young people to develop solutions to the impacts of HIV and Hep C stigma on youth in what is now called British Columbia.

    Support:
    Organization of this symposium is supported by members of the Conference nə́c̓aʔmat ct Indigenous Sexual Health Committee. Financial support for this symposium is provided by the BC Centre for Disease Control, First Nations Health Authority, Indigenous Services Canada, and the Vancouver Foundation.

  • 10:45 - 12:15

    Symposium 9 - Prevention and care cascades

    Location: MR 11+12, East Building, Vancouver Convention Centre

    Talk 1. The relationship between demographics, health needs and the HIV care cascade outcomes: From infection to viral suppression
    - Abigail Kroch, Ontario HIV Treatment Network (OHTN), Canada

    Talk 2. Cascade of HIV prevention: A powerful tool to improve the implementation of DREAMS combination prevention in rural South Africa
    - Maryam Shahmanesh, London’s Global University, UK

    Talk 3. Application of a cascade approach for guiding prevention of congenital syphilis
    - Patricia Garcia, Universidad Peruana Cayetano Heredia, Peru

    Talk 4. Cascades and other approaches to guide PrEP programming
    - Sinead Delany-Moretlwe, Wits Reproductive Health and HIV Institute, South Africa

  • 10:45 - 12:15

    Symposium 10 - STIs in low and middle-income countries: Resurgent infections and evolving control measures

    Location: MR 8+15, East Building, Vancouver Convention Centre

    Talk 1. High rates of curable STIs in low and middle income countries
    - Connie Celum, University of Washington, USA

    Talk 2. Building STD clinical infrastructure in LMIC – Role of general vs. specialized infrastructure
    - Ligang Yang, Southern Medical University, China 

    Talk 3. Cervical cancer prevention in LMICS: Are we on the path to elimination?
    - Megan Huchko, Duke University, USA

    Talk 4. Self-care interventions for sexual and reproductive health and rights
    - Manjulaa Narasimhan, World Health Organization, Switzerland

  • 10:45 - 12:15

    Symposium 11 - Research on the vaginal microbiome: Advances & controversies

    Location: MR 1 East Building, Vancouver Convention Centre

    Talk 1. Introduction to the vaginal microbiome preconference symposium
    - Jeanne Marrazzo, University of Alabama at Birmingham School of Medicine, USA

    Talk 2. Lessons learned from the pre-meeting symposium on characterizing the vaginal microbiota through a blinded multi-laboratory collaboration
    - Jen Balkus, University of Washington, USA

    Talk 3. The vaginal microenvironment prior to incident STI
    - Rebecca Brotman, University of Maryland School of Medicine, USA

    Talk 4. Role of the genital tract microbiome in sexual and reproductive health: Report from the Keystone Symposium in Cape Town, 2018
    - Janneke van de Wijgert, University of Liverpool, UK and University Medical Center Utrecht, The Netherlands

  • 10:45 - 12:15

    Oral Presentation Session 8 - Getting real with implementing PrEP 1: Gay, bisexual and other men who have sex with men

    Location: Ballroom, East Building, Vancouver Convention Centre

    Talk 1. Pre-exposure prophylaxis in Brazil: Opportunities and challenges for men who have sex with men, Brazil, 2018
    - Diego Calixto, Ministry of Health of Brazil, Brazil

    Talk 2. Sexual behaviour, risk and sexually transmitted infections before and after the introduction of the PrEP impact trial
    - Louis MacGregor, University of Bristol, UK

    Talk 3. Rates of chlamydia and gonorrhea testing and positivity before and after initiation of PrEP among MSM in US private settings
    - Guoyu Tao, Centers for Disease Control and Prevention, USA

    Talk 4. Influence of HIV-status and PrEP use on high STI prevalences in MSM in Germany, 2018
    - Klaus Jansen, Robert Koch Institute, Germany

    Talk 5. Trends in bacterial STI incidence and impact of PrEP use among MSM attending Western Sydney sexual health centre (2013-2018)
    - David Lewis, Western Sydney Local Health District, Australia

    Talk 6. Frequency and determinants of switching between daily or event-driven PrEP and discontinuing each regimen in Amsterdam MSM
    - Liza Coyer, Public Health Service of Amsterdam, The Netherlands

  • 10:45 - 12:15

    Oral Presentation Session 9 - Epidemiology and surveillance to inform practice and policy

    Location: MR 13, East Building, Vancouver Convention Centre

    Talk 1. The Netherlands chlamydia cohort study: Pregnancies in women with and without a previous chlamydia infection
    - Bernice Hoenderboom, National Institute for Public Health and the Environment, The Netherlands

    Talk 2. Declines in chlamydia-associated PID at SSHS in England since 2007: What might this tell us about chlamydia control?
    - Paddy Horner, University of Bristol, UK

    Talk 3.Potential Neisseria gonorrhoeae outbreak in heterosexuals younger than 25 revealed three clusters by culture-free genotyping
    - Brian Van Der Veer, Maastricht University Medical Center (MUMC+), The Netherlands

    Talk 4. HIV and HCV among clients of female sex workers in Dnipro, Ukraine
    - Marissa Becker, University of Manitoba, Canada

    Talk 5. Hepatitis C incidence rate among people who inject drug (PWID) in British Columbia from 2000 to 2015
    - Yiqiao Li, British Columbia Center for Disease Control, Canada

    Talk 6. Development of an integrated data mart for surveillance of sexually transmitted and bloodborne infections (STIBBI)
    - Jason Wong, BC Centre for Disease Control, Canada

  • 13:45 - 14:20

    Plenary 9 - Understanding chlamydia pathogenesis

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    Kevin Hybiske, University of Washington, USA

  • 14:20 - 14:55

    Plenary 10 - The global HIV response at 40

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    David Wilson, World Bank, USA

  • 14:55 - 15:30

    Plenary 11 - Global health legacies, sustainable development goals, and implications for sexual & reproductive health

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    David Peters, Johns Hopkins University, USA

  • 15:45 - 16:15

    Coffee Break

    Location: Exhibit Hall, East Building, Vancouver Convention Centre
  • 16:15 - 17:45

    Symposium 12 - New approaches for STI vaccines

    Location: MR 2+3, East Building, Vancouver Convention Centre

    Talk 1. Progress towards a gonorrhea vaccine
    - Kate Seib, Griffith University, Australia

    Talk 2. A tri-antigen protective syphilis vaccine design that enhances treponemal clearance and inhibits pathogen dissemination
    - Lorenzo Giacani, University of Washington, USA

    Talk 3. Therapeutic vaccination to treat HPV disease: Lessons learned from high grade intraepithelial lesions
    - Margaret Madeleine, Fred Hutchinson Cancer Research Center, USA

    Talk 4. A mucosal Chlamydia trachomatis vaccine stimulates protective memory T cells
    - Michael Starnbach, Harvard University, USA

  • 16:15 - 17:45

    Symposium 13 - Controversies in clinical STI care

    Location: MR 11+12, East Building, Vancouver Convention Centre

    Talk 1. Does azithromycin have a future in the treatment of gonorrhoea and chlamydial infection?
    - Jane Hocking, University of Melbourne, Australia

    Talk 2. Should enteric infections in MSM always be treated?
    - Mark Pakianathan, St George’s University Hospital Foundation Trust, UK

    Talk 3. Do rectal bacterial STIs in women matter? Who should we test and when?
    - Christine Khosropour, University of Washington, USA

    Talk 4. HPV vaccination in MSM: Who should be vaccinated and is there a role for vaccination of older and/or HIV-positive MSM in preventing initial, persistent and recurrent HPV and related diseases?
    - David Templeton, University of Sydney, Australia

  • 16:15 - 17:45

    Symposium 14 - Sexual networks and STI transmission: From modelling to practice

    Location: Ballroom, East Building, Vancouver Convention Centre

    Talk 1. Sexual contact networks, STI transmission and the effectiveness of interventions: Insights from mathematical modelling
    - Christian Althaus, University of Bern, Switzerland

    Talk 2. Use of whole genome sequencing to explore transmission between sexual networks in an STI outbreak
    - Helen Fifer, Public Health England, UK

    Talk 3. Maximizing the acceptability, feasibility and validity of sexual network studies: Lessons from the field
    - Abby Norris Turner, Ohio State University, USA

    Talk 4. The role of sexual networks in the global spread of antimicrobial-resistance enteric infections
    - Nigel Field, University College London, UK

  • 16:15 - 17:45

    Oral Presentation Session 10 - Getting real with implementing PrEP 2

    Location: MR 8+15, East Building, Vancouver Convention Centre

    Talk 1. HIV pre-exposure prophylaxis (PrEP) indications and uptake vary by race, gender and insurance in a large clinic network
    - Maria Pyra, Howard Brown Health, USA

    Talk 2. Impact of HIV-PrEP for female-sex-workers on community-wide awareness, uptake and perceptions in a rural-area Kwazulu-Natal
    - Natsayi Chimbindi, Africa Health Research Institute (AHRI), South Africa

    Talk 3. High curable STI prevalence and incidence among young African women initiating PrEP in HPTN 082
    - Sinead Delany-Moretlwe, University of the Witwatersrand, South Africa

    Talk 4. Scaling up HCV screening and treatment for eliminating HCV among MSM in UK in the era of HIV pre-exposure prophylaxis
    - Louis MacGregor, University of Bristol, UK

    Talk 5. Patterns of HIV pre-exposure prophylaxis care one year after initiating PrEP, Baltimore City, Maryland 2015-2018
    - Linxuan Wu, Johns Hopkins School of Medicine, USA

    Talk 6. A longitudinal analysis of men who have sex with men’s condom use and attitudes during HIV antiretroviral prevention scale-up
    - Nathan Lachowsky, University of Victoria, Canada

  • 16:15 - 17:45

    Oral Presentation Session 11 - Improving the equity and effectiveness of sexual health care

    Location: MR 1, East Building, Vancouver Convention Centre

    Talk 1. An update on the performance of STI services for gay and bisexual men across 40 cities: Preliminary results from EMIS-2017
    - Jason Doran, London School of Hygiene and Tropical Medicine, Ireland

    Talk 2. How do the sexual networks of men who have sex with men in one mid-Atlantic city differ by race/ethnicity?
    - Jessica Wagner, Johns Hopkins University School of Medicine, USA

    Talk 3. “You feel invisible”: A qualitative exploration of young LGBT+ people’s attitudes towards STI/HIV testing in primary care
    - Lorraine McDonagh, University College London, UK

    Talk 4. Trans & gender diverse people's experiences of sexual health care are associated with sexual health screening uptake
    - Denton Callander, New York University, USA

    Talk 5. Impact of HIV self-testing on the promotion of HIV testing among men who have sex with men in China: A randomized controlled trial
    - Weibin Cheng, Dermatology Hospital of Southern Medical University, China

    Talk 6. Trends in chlamydia screening and pap testing among US females by age and race; National Survey of Family Growth, 2006-2017
    - Laura Haderxhanaj, Centers for Disease Control and Prevention, USA

  • 16:15 - 17:45

    Oral Presentation Session 12 - Understanding relationships and partner strategies for STI control

    Location: MR 13, East Building, Vancouver Convention Centre

    Talk 1. Exploring relationship duration among gay and bisexual men: A longitudinal event-level analysis
    - Kiffer Card, University of Victoria, Canada

    Talk 2. Partnership context and consistent condom use among young African American men
    - Megan Clare Craig-Kuhn, Tulane University School of Public Health and Tropical Medicine, USA

    Talk 3. Epidemiological impact of expedited partner therapy for men who have sex with men: A modeling study
    - Kevin Weiss, Emory University, USA

    Talk 4. Effects of enhanced STI partner notification counselling in Cape Town: Randomized controlled trial
    - Catherine Mathews, South African Medical Research Council, South Africa

    Talk 5. Partner notification outcomes for chlamydia/gonorrhea cases diagnosed through clinics vs GetCheckedOnline in British Columbia
    - Arina Zamanpour, British Columbia Centre for Disease Control, Canada

    Talk 6. Contact tracing vs patient-delivered partner treatment for African American heterosexual men with chlamydia
    - Patricia Kissinger, Tulane School of Public Health and Tropical Medicine, USA

  • 17:45 - 19:00

    Poster Viewing Session

    Location: Exhibit Hall, East Building, Vancouver Convention Centre
  • 19:30 - 22:00

    Congress Dinner (Ticketed Event)

    Location: Ballroom C & D West Building Vancouver Convention Centre

WednesdayJuly 17, 2019

  • 07:00 - 08:00

    Clinical Case Series - Cases from the clinic

    Location: MR 8+15, East Building, Vancouver Convention Centre

    Talk 1. Rapid PrEP reinitiation in a patient with ongoing risk
    - Negusse Ocbamichael PA-C, STD Clinic/Public Health-Seattle & King County at Harborview, USA

    Talk 2. Neonatal HSV: Could this transmission have been prevented?
    - Elizabeth Foley, Solent NHS Trust, UK

  • 07:00 - 08:00

    ASTDA Young Investigator Mentor/Mentee Breakfast Session: Sexual harassment in sexual health professions: Breaking silence and making solutions

    Location: MR 11+12, East Building, Vancouver Convention Centre

    Speakers:

    Dennis Fortenberry, Director of Adolescent Medicine, Indiana University, USA

    Caroline Cameron, University of Victoria, Canada

  • 08:15 - 08:50

    Plenary 12 - Overview on the development of point-of-care tests for detection of antimicrobial resistance – challenges and opportunities

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    Johan Melendez, Johns Hopkins University, USA

  • 08:50 - 09:25

    Plenary 13 - The role of key population-led health services in addressing the challenge of STI and HIV

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    Rena Janamnuaysook, The Thai Red Cross AIDS Research Centre, Thailand

  • 09:25 - 10:15

    Debate - Among men who have sex with men, pharyngeal infection contributes more to population levels of gonorrhea transmission than urethral infection, rectal infection, or both?

    Location: Ballroom, East Building, Vancouver Convention Centre

    Chair(s):

    Kyle Bernstein, Centers for Disease Control and Prevention, USA

    Speaker(s):

    For the motion: Christopher Fairley, Monash University, Australia

    Against the motion: Hunter Handsfield, University of Washington, USA

  • 10:15 - 10:45

    Coffee Break

    Location: Exhibit Hall, East Building, Vancouver Convention Centre
  • 10:45 - 12:15

    Symposium 15 - New approaches to STI diagnosis and prevention

    Location: Ballroom, East Building, Vancouver Convention Centre

    Talk 1. Four Treponema pallidum proteins detected in urine from syphilis-infected individuals using mass spectrometry
    - Chris Kenyon, Institute of Tropical Medicine, Belgium

    Talk 2. CRISPR diagnostics: Expanding the nucleic acid detection toolbox by harnessing microbial diversity
    - Jonathan Gootenberg, Massachusetts Institute of Technology, USA

    Talk 3. Reducing the global burden of infectious diseases through precision infection management (PIM)
    - Ian Lewis, University of Calgary, Canada

    Talk 4. Combatting HIV with nanomaterials
    - Kim Woodrow, University of Washington, USA

  • 10:45 - 12:15

    Symposium 16 - Anatomical sites of infection: Biomedical, modeling, behavioural, and programmatic considerations for STI prevention

    Location: MR 2+3, East Building, Vancouver Convention Centre

    Talk 1. Anatomical sites of infection: Biomedical considerations for STI prevention
    - Jane Hocking, University of Melbourne, Australia

    Talk 2. Modelling considerations related to multi-site infection
    - Ian Spicknall, Centers for Disease Control and Prevention, USA

    Talk 3. Anatomical sites of infection: Behavioural considerations for STI prevention
    - Catherine Mercer, University College London, UK

    Talk 4. Designing an approach to deal with extragenital sexually transmitted infections: Do we have the data we need?
    - Jeanne Marrazzo, University of Alabama, USA

  • 10:45 - 12:15

    Symposium 17 - Clinical issues in women’s health and STI

    Location: MR 11+12, East Building, Vancouver Convention Centre

    Talk 1. HPV screening – New evidence and current state of the art
    - Suzanne Garland, The Royal Women’s Hospital, Australia

    Talk 2. Treatment of Bacterial vaginosis: How, when and how much?
    - Caroline Mitchell, Harvard University, USA

    Talk 3. Screening women for bacterial STIs: Should we scale back?
    - Jonathan Ross, University of Birmingham, UK

    Talk 4. Prematurity and STI – value of screening and treatment
    - Deborah Money, University of British Columbia, Canada

  • 10:45 - 12:15

    Symposium 18 - Regional responses to global HIV/STI trends - IUSTI Special Symposium

    Location: MR 13, East Building, Vancouver Convention Centre

    Talk 1. An update on the status of HIV/STIs in IUSTI's five regions
    - John Kaldor, The Kirkby Institute, Sydney, Australia

    Talk 2. Bridging the gap - best practice global examples of integration of HIV and STI services
    - Janet Wilson, National Health Service, UK

    Talk 3. Improving the sexual and reproductive health of women living with HIV
    - Angelica Espinosa Miranda, Universidade Federal do Espirito Santo, Brazil

    Talk 4. Engaging culturally and linguistically diverse populations in HIV/STI services: Challenges and opportunities
    - Shailendra Sawleshwarkar, The University of Sydney, Australia

  • 10:45 - 12:15

    Oral Presentation Session 13 - Working towards sexual health equity: Understanding context

    Location: MR 1, East Building, Vancouver Convention Centre

    Talk 1. Factors associated with safer sex efficacy among Northern and indigenous youth in the Northwest Territories, Canada
    - Carmen Logie, University of Toronto, Canada

    Talk 2. Mixed methods analysis: Role of parents, peers and perceived severity of sexual health outcomes among Native American youth
    - Lauren Tingey, Johns Hopkins University, USA

    Talk 3. High prevalence of cervico-vaginal infections among female adolescents in four urban regions of Panama
    - Amanda Gabster, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panama

    Talk 4. Patterns of drug use among MSM in Amsterdam and sexually transmitted infections, The Netherlands: A cluster analysis
    - Roel Achterbergh, Public Health Service of Amsterdam, The Netherlands

    Talk 5. Reaching home-based female sex workers with preventive sexual health care services in The Netherlands
    - Charlotte Peters, South Limburg Public Health Services, The Netherlands

    Talk 6. Precarious legal immigration status linked to client condom refusal among sex workers in Metro Vancouver (2010-2018)
    - Bronwyn McBride, Centre for Gender and Sexual Health Equity, Canada

  • 10:45 - 12:15

    Oral Presentation Session 14 - Improving the access and impact of STI testing

    Location: MR 8+15, East Building, Vancouver Convention Centre

    Talk 1. Optimizing screening for chlamydia: Is there a role for screening heterosexual men?
    - Minttu Rönn, Harvard T.H. Chan School of Public Health, USA

    Talk 2. Can community Chlamydia trachomatis screening of young heterosexual men help identify infected networks?
    - Patricia Kissinger, Tulane School of Public Health and Tropical Medicine, USA

    Talk 3. Disparities in access to HIV point-of-care testing: The non-urban Canadian context
    - Jacqueline Gahagan, Dalhousie University, Canada

    Talk 4. Implementation of point of care gonorrhea and chlamydia testing in an STD clinic PrEP program, San Francisco, 2017-2018
    - Stephanie Cohen, San Francisco Department of Public Health, USA

    Talk 5. Chlamydia trachomatis testing: A national evaluation of internet based self-sampling in Sweden
    - Björn Herrmann, Uppsala University Hospital, Sweden

    Talk 6. mAfrica: Zenzele, a mobile-phone enabled HIV testing and linkage to care pathway for young people in rural South Africa
    - Maryam Shahmanesh, University College London, UK

  • 10:45 - 12:15

    Oral Presentation Session 15 - Understanding perceptions and beliefs: Improving STI/HIV interventions and outcomes

    Location: MR 9, East Building, Vancouver Convention Centre

    Talk 1. “A PrEP user is someone who has a lot of bareback”: A qualitative study of acceptability of PrEP in MSM in Lebanon
    - Ismael Maatouk, Clemenceau Medical Center, Lebanon

    Talk 2. Interested? Why or why not? STI clinic client perceptions of bacterial STI vaccines in British Columbia, Canada
    - Kara Plotnikoff, University of British Columbia, Canada

    Talk 3. Development of a scale measuring stigma towards alcohol abstinence among people living with HIV in Vietnam
    - Kathryn Lancaster, The Ohio State University, USA

    Talk 4. Predictors of incorrect HIV care initiation beliefs among people living with HIV/AIDS in Chókwè District, Mozambique
    - Christine Hara, Public Health Institute, Mozambique

    Talk 5. Syphilis risk perceptions among repeatedly infected men who have sex with men in Beirut, Lebanon
    - Ismael Maatouk, Clemenceau Medical Center, Lebanon

    Talk 6. Women’s approaches to involving others in making HIV trial enrollment decisions while pregnant in the US and Malawi
    - Kristen Sullivan, University of North Carolina at Chapel Hill, USA

  • 13:45 - 15:15

    Symposium 19 - Global public health approaches to gonorrhea prevention and the threat of antibiotic resistance

    Location: MR 11+12, East Building, Vancouver Convention Centre

    Talk 1. Perspectives from North America
    - Karen Schlanger, Center for Disease Control and Prevention, USA

    Talk 2. Perspectives from Brazil and Latin America
    - Adele Schwartz Benzaken, Tropical Medicine Foundation, Manaus, Amazonas, Brazil

    Talk 3. Perspectives from Thailand
    - Pachara Sirivongrangson, Thailand Ministry of Public Health, Thailand

    Talk 4. Public health approaches to gonorrhea prevention and the threat of antibiotic resistance – perspectives from Europe
    - Otilia Mårdh, European Centre for Disease Prevention and Control (ECDC), Sweden

  • 13:45 - 15:15

    Symposium 20 - Criminalization, the law and sexual health

    Location: Ballroom, East Building, Vancouver Convention Centre

    Talk 1. Understanding how laws and policies affect HIV prevention practices: A theoretical approach
    - Morten Skovdal, University of Copenhagen, Denmark

    Talk 2. Intersectionality, criminalisation and sexual health
    - Carmen Logie, University of Toronto, Canada

    Talk 3. The health impacts of sex work criminalization: A review of the evidence 
    - Lucy Platt, The London School of Hygiene & Tropical Medicine, UK 

    Talk 4. Criminalisation of HIV transmission in the era of U=U 
    - Michael Brady, Kings College Hospital/Terrence Higgins Trust, UK

  • 13:45 - 15:15

    Symposium 21 - Building a human infrastructure for STI prevention: Beyond community engagement, consultation and advisory boards

    Location: MR 2+3, East Building, Vancouver Convention Centre

    Talk 1. Youth and community based research
    - Sarah Flicker, York University, Canada

    Talk 2. Addressing anti-LGBT stigma and medical mistrust through a data-informed approach to community engagement
    - Errol Fields, Johns Hopkins University, USA

    Talk 3. Authentic and successful community engagement for STI/HIV prevention, screening, and treatment in rural and urban settings
    - Scott Rhodes, Wake Forest School of Medicine, USA

    Talk 4. Spurring innovation in improving community engagement for STI prevention
    - Weiming Tang, University of North Carolina Project-China, China

  • 13:45 - 15:15

    Oral Presentation Session 16 - Host-pathogen interactions

    Location: MR 9, East Building, Vancouver Convention Centre

    Talk 1. Therapeutic effect of indoleamine 2,3-dioxygenase (IDO) inhibitor in the male genital inflammation
    - Shin Ohira, Kawasaki Medical School, Japan

    Talk 2. Mapping regions of host attachment in the T. pallidum adhesin Tp0751; Function-informed vaccine design
    - Sean Waugh, University of Victoria, Canada

    Talk 3. Cytokine immune response against natural human papillomavirus infection among men in Kisumu, Kenya
    - Raphael Ondondo, Masinde Muliro University of Science and Technology, Kenya

    Talk 4. Structural similarity of Treponema pallidum protein Tp0225 with human toll-like receptor 2
    - Simon Houston, University of Victoria, Canada

    Talk 5. Targeting complement receptor 3 on primary human cervical cells has the potential to cure Neisseria gonorrhoeae infection
    - Jennifer Edwards, The Research Institute at Nationwide Children's Hospital and The Ohio State University, USA

    Talk 6. Basic science aids syphilis vaccine development: Bloodstream spreading by the syphilis spirochete Treponema pallidum
    - Karen Lithgow, University of Victoria, Canada

  • 13:45 - 15:15

    Oral Presentation Session 17 - Screening and vaccination

    Location: MR 1, East Building, Vancouver Convention Centre

    Talk 1. HPV FOCAL 48 month exit results by age for women HPV or LBC negative at baseline screening
    - Gina Ogilvie, University of British Columbia, Canada

    Talk 2. Women's experiences with primary human papillomavirus (HPV) testing for cervix screening: HPV FOCAL exit survey results
    - Laurie Smith, BC Cancer, Canada

    Talk 3. Declining rates of cervical intraepithelial neopleasia after introduction of the HPV vaccine in British Columbia, Canada
    - Robine Donken, BC Children’s Research Institute, Canada

    Talk 4. Impact of the human papillomavirus immunization program on rates of anogenital warts in British Columbia, Canada 2000-2017
    - Christine Lukac, University of British Columbia, Canada

    Talk 5. Declining trends in anogenital warts since HPV vaccine introduction in a large urban health system, 2013-2017
    - Linda Niccolai, Yale School of Public Health, USA

    Talk 6. Parents'/healthcare providers' knowledge, attitude and perception of school-based HPV vaccination program in Lagos, Nigeria
    - Adebola Adejimi, College of Medicine, University of Lagos, Nigeria

  • 13:45 - 15:15

    Oral Presentation Session 18 - Pills of white mercury: Syphilis prevalence, screening and prevention

    Location: MR 13, East Building, Vancouver Convention Centre

    Talk 1. Prevalence of active syphilis among transwomen in São Paulo, Brazil
    - Beatriz Paiatto, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Brazil

    Talk 2. Estimating disease burden of maternal syphilis and associated adverse pregnancy outcomes in China
    - Yajie Wang, Dermatology Hospital of Southern Medical University, China

    Talk 3. Development of a syphilis serum repository for research and evaluation of syphilis diagnostics tests in the United States
    - Mayur Shukla, Centers for Disease Control and Prevention, USA

    Talk 4. Evaluation of routinized syphilis screening with HIV viral loads among men living with HIV
    - Ann Burchell, St. Michael's Hospital, Canada

    Talk 5. HIV seropositivity and early syphilis stage predictive of ocular syphilis diagnosis in British Columbia, Canada: 2010-2018
    - Hasan Hamze, University Of British Columbia, Canada

    Talk 6. Prenatal care entry among pregnant women with syphilis who use methamphetamines: A key to congenital syphilis prevention
    - Rosalyn Plotzker, California Department of Public Health, USA

  • 13:45 - 15:15

    Oral Presentation Session 19 - Models, networks and transmission dynamics: New insights for programs

    Location: MR 8+15, East Building, Vancouver Convention Centre

    Talk 1. Model-based study design for estimation of route-specific gonorrheal transmission probabilities
    - Ethan Romero-Severson, Los Alamos National Laboratory, USA

    Talk 2. Bridging of Neisseria gonorrhoeae across diverse sexual networks in the HIV PrEP era
    - Deborah Williamson, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Australia

    Talk 3. Partner services for gonorrhea can decrease new HIV among MSM in King County, Washington: A mathematical modeling study
    - Gui Liu, University of Washington, USA

    Talk 4. Molecular epidemiology of HIV among foreign-born residents of King County, Washington, USA; Using HIV surveillance data
    - Diana Tordoff, University of Washington, USA

    Talk 5. The influence of risk group turnover in STI/HIV epidemics: Mechanistic insights from transmission modeling
    - Jesse Knight, St. Michael's Hospital, Canada

    Talk 6. Professional injectors, injection networks, and HIV: Case studies from five cities in Pakistan
    - Laura Thompson, University of Manitoba, Canada

  • 15:15 - 15:45

    Coffee Break

    Location: Exhibit Hall, East Building, Vancouver Convention Centre
  • 15:45 - 16:45

    Closing Keynote Lecture - Making science work to deliver effective programmes at scale

    Location: Ballroom, East Building, Vancouver Convention Centre

    Speaker(s):

    Charlotte Watts, UK Department of International Development (DFID), UK

  • 16:45 - 18:00

    Closing Ceremony

    Location: Ballroom, East Building, Vancouver Convention Centre

Congress Newsletter

Close

Subscribe to the Newsletter to receive important information about the upcoming congress.